Supply chain management in the pharmaceutical industry in Poland 2008

DESCRIPTION

Supply chain management in the pharmaceutical industry in Poland 2008 thoroughly examines the most innovative ways of gaining competitive advantage in the pharmaceutical sector. It studies the conditions and the level of advancement of the Supply Chain Management on the Polish market in the
context of the best practices employed in Polish enterprises and worldwide. The concept itself is meticulously explained, focusing on drug production in Poland.
Key objectives and solutions offered by the SCM in Polish companies are provided on the basis of empirical data gathered specifically for the purpose of this report.

Key sections

Section one analyses the ways pharmaceutical manufacturers manage supply chains. It provides details related to supply chain planning and supply and demand synchronisation. It also discusses SCM impact on customer service, the production and distribution of pharmaceuticals, as well as supply and
redistribution.
Section two investigates SCM integration in Polish companies in the context of the best practices employed abroad. It discusses the SCM strategies employed by Polish companies and internal conditions for SCM implementation. It also analyses the integration of SCM processes and their legal
framework, comparing loopholes on Polish and foreign markets.
Section three looks into the development of SCM in Polish pharmaceutical companies, focusing on its growth drivers and conditions. It presents SCM as an innovative tool to efficiently improve company competitiveness, and analyses threats and opportunities for SCM growth in Polish pharmaceutical
companies.

Report overview

The report opens with an introduction presenting its objectives and target readership. It then introduces research methods employed in the study and provides a summary and a presentation of its most important conclusions. What follows is a thorough analysis of the supply chains used by pharmaceutical manufacturers, with special attention given to the following aspects:

• supply chain planning: supply and demand synchronisation
• customer service
  
• distribution
  
• production
  
• supply
  
• redistribution.
  

It then discusses the integration of SCM within Polish pharmaceutical companies, in the context of the best practices employed worldwide. It focuses on the following elements:

• SCM strategies of Polish pharmaceutical companies
• internal conditions for SCM in Polish pharmaceutical companies
  
•  
• integration of SCM processes
  
•  
• loophole analysis: Polish companies versus global tendencies
  

• SCM as a tool to improve competitiveness
• threats and opportunities for SCM growth in pharmaceutical companies in Poland.

• top management of pharmaceutical companies in Poland and abroad
• logistic operators active on the pharmaceutical market and those planning to enter it
• pharmaceutical company managers interested in implementing Supply Chain Management methods
• supply chain managers
• pharmaceutical distributors
• researchers, market analysts and consultants
• academic institutions
• those wanting to gain a thorough understanding of the Supply Chain Management concept.

TABLE OF CONTENT

Report methodology 9
Introduction 15
Executive summary 19
Model of an excellent supply chain in the pharmaceutical industry 25

• Basic features of the supply chain 25
• Stages of SCM advancement 26
• Scope of research carried out for the purposes of the report 28

Diagnosis of supply chains of producers in the pharmaceutical industry 31

• Subjective structure of the supply chain 31
  • Problems identified in the subjective structure of the drug supply chain in Poland 32
  • Most important tendencies in the subjective structure of drug supply chains in Poland 33
• Objective structure of the supply chain 33
  • Regulations of pharmaceutical products demand and supply 33
    • Innovative and generic medicines 34
    • Rx and OTC medicines 34
  • Problems identified in the objective structure of supply chains in Poland 37
  • Most important trends in the objective structure of drug supply chains in Poland 37
• Selected processes in the pharmaceutical supply chain 38
  • Supply chain planning – synchronisation of demand and supply 39
  • Customer service 42
  • Physical distribution (transport, storage) 44
  • Manufacturing 54
  • Supplies (relations with suppliers) 56
  • Redistribution – management of returns and waste 58
  • Marketing activities 59
  • Designing and launching new products 61
• Summary 63

Survey-based assessment of the level of SCM
integration in the pharmaceutical industry in Poland 65

• Results of the survey carried out amongst companies present on the pharmaceutical market in Poland 65
  • Sample characteristic 65
  • Source of competitive edge in pharmaceutical companies in Poland 68
  • Knowledge of SCM concepts in pharmaceutical companies in Poland 68
  • Assessment of strategic gap in SCM in Poland 69
• Analysis of best practices – selected directions of improving SCM in the Polish pharmaceutical industry 73
  • SCM strategies in the pharmaceutical industry 73 Case study 1 – SCM strategy in Bayer Pharmaceuticals 73
• Internal SCM conditions in pharmacy (organisational structure supporting SCM) 78
  • Case study 2 – Organisational changes in Becton Dickinson 78
  • Case study 3 – Organisational structure for the Baxter Poland supply chain 80
• Pharmaceutical supply chain controlled by actual demand 82
  • Case Study 4 – Direct distribution – Poltraf 83
  • Case Study 5 – Joint forecasting and planning in Bayer AG 84
  • Case study 6 – Demand management in the supply chain in Procter & Gamble 85
• Customer service in the pharmaceutical supply chain 86
  • Case study 7 – Customer service in the supply chain of Procter & Gamble 87
• Leaning of the pharmaceutical supply chain – manufacturing processes 88
  • Case study 8 – Lean production of copolymer producer 89
• Integration of suppliers by medicine producers 91
  • Case study 9 – Integration of suppliers in a global pharmaceutical company 91

Premises and conditions of the development of
SCM in the Polish pharmaceutical industry 97

• SCM and improved company competitiveness 97
• Opportunities and threats of SCM development in pharmaceutical companies in Poland 99

Annex 1 Detailed list of answers of respondents
– SCM diagnosis in the Polish pharmaceutical
industry 103
List of graphs 105
List of tables 107
About PMR 109
Contact PMR 110

By ordering a "single user licence" the client is purchasing the right to use the publication on one computer workstation only. Any copying, distribution or dissemination of the electronic publication via a computer network (in part or in whole) is strictly prohibited. Delivered by e-mail in PDF format.

By ordering a "5-user licence" the client is purchasing a licence authorising the copying, distribution and dissemination of the electronic publication via a computer network (in part or in whole) among a maximum of 5 people within the company indicated on the order form (including all company subsidiaries in a single country location). Delivered by e-mail in PDF format.

By ordering a "company licence" the client is purchasing a licence authorising the unrestricted copying, distribution and dissemination of the electronic publication (in part or in whole) via a computer network solely within the company indicated on the order form (including all company subsidiaries in a single country location). CD delivered by courier. CD version contains PDF version of the report plus an extra file with all the graphs and tables in a copiable format easy to use in your own analyses, presentations, etc.

By ordering a "global licence" the client is purchasing a licence authorising the unrestricted copying, distribution and dissemination of the electronic publication (in part or in whole) via a computer network solely within the organisation indicated on the order form, regardless of country location. CD delivered by courier. CD version contains PDF version of the report plus an extra file with all the graphs and tables in a copiable format easy to use in your own analyses, presentations, etc.